WIBP‐CorV – Sinopharm‐Wuhan vs placebo
Local reactogenicity events
WIBP‐CorV – Sinopharm‐Wuhan leads to lower local reactogenicity eventsk compared with placebo (high certainty).
1 finding from 1 review
- RR 0.88 [0.85, 0.92]2 studies · 27029 participantsHigh